EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,511 | -24.7% | 14,300 | -7.1% | 0.01% | -18.2% |
| Q2 2023 | $299,376 | -58.5% | 15,400 | -39.5% | 0.01% | -63.3% |
| Q1 2023 | $722,045 | +240.1% | 25,451 | +250.4% | 0.03% | +172.7% |
| Q4 2022 | $212,327 | -11.2% | 7,264 | +54.6% | 0.01% | -26.7% |
| Q4 2021 | $239,000 | -15.2% | 4,700 | -28.8% | 0.02% | -44.4% |
| Q2 2021 | $282,000 | +22.6% | 6,600 | +20.0% | 0.03% | +28.6% |
| Q1 2021 | $230,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |